SERTRALINE

SERTRALINE was reported 119291 times

SERTRALINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE ACYL-COENZYME A DEHYDROGENASE DEFICIENCY 315 0.7377
1 TOTAL LUNG CAPACITY INCREASED 76 0.2794
2 AGITATION NEONATAL 160 0.1668
3 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 76 0.1453
4 RESPIRATORY DISORDER NEONATAL 214 0.1319
5 AMAUROSIS FUGAX 133 0.1235
6 ANORGASMIA 323 0.1189
7 DISTURBANCE IN SEXUAL AROUSAL 100 0.1087
8 OROMANDIBULAR DYSTONIA 79 0.1084
9 SEROTONIN SYNDROME 1980 0.1030
10 INTRUSIVE THOUGHTS 121 0.1027
11 GENITAL HYPOAESTHESIA 98 0.0960
12 ORGASM ABNORMAL 77 0.0952
13 HYPOMANIA 327 0.0888
14 EMOTIONAL POVERTY 148 0.0844
15 BRUXISM 454 0.0841
16 INTENTIONAL SELF-INJURY 1615 0.0799
17 BUTTERFLY RASH 78 0.0769
18 DEREALISATION 148 0.0687
19 COLITIS MICROSCOPIC 324 0.0683
20 OBSESSIVE THOUGHTS 108 0.0599
21 YAWNING 155 0.0581
22 ANTIPSYCHOTIC DRUG LEVEL INCREASED 163 0.0578
23 DEPRESSION SUICIDAL 197 0.0569
24 SELF-INJURIOUS IDEATION 237 0.0564
25 SMALL FOR DATES BABY 280 0.0563
26 PSYCHIATRIC DECOMPENSATION 110 0.0562
27 FLAT AFFECT 128 0.0552
28 PSYCHOMOTOR RETARDATION 155 0.0551
29 HYPERREFLEXIA 192 0.0551
30 DEPRESSIVE SYMPTOM 189 0.0536
31 HALLUCINATIONS, MIXED 217 0.0515
32 PSYCHOMOTOR SKILLS IMPAIRED 132 0.0503
33 SEXUAL DYSFUNCTION 587 0.0500
34 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 97 0.0491
35 HYPERPARATHYROIDISM SECONDARY 123 0.0490
36 LOSS OF LIBIDO 439 0.0488
37 PSYCHOTIC SYMPTOM 99 0.0479
38 CLONUS 131 0.0478
39 TEARFULNESS 201 0.0467
40 ALCOHOL INTERACTION 90 0.0463
41 AKATHISIA 625 0.0458
42 ELECTRIC SHOCK SENSATION 128 0.0457
43 HOMICIDE 84 0.0456
44 ATRIAL SEPTAL DEFECT 380 0.0453
45 PATENT DUCTUS ARTERIOSUS 180 0.0453
46 PARKINSONISM 437 0.0448
47 POISONING DELIBERATE 424 0.0447
48 SUICIDAL BEHAVIOUR 185 0.0444
49 CATATONIA 231 0.0439
50 SEDATION COMPLICATION 107 0.0419
51 NEPHROGENIC ANAEMIA 193 0.0416
52 INTENTIONAL OVERDOSE 2642 0.0411
53 SUSPECTED SUICIDE 193 0.0411
54 GESTATIONAL DIABETES 193 0.0405
55 TALIPES 124 0.0399
56 NEUROLEPTIC MALIGNANT SYNDROME 473 0.0398
57 TIC 214 0.0392
58 FOAMING AT MOUTH 78 0.0386
59 BRADYKINESIA 225 0.0381
60 REBOUND ACID HYPERSECRETION 115 0.0380
61 MYOCLONUS 450 0.0377
62 TRISMUS 193 0.0373
63 ACUTE PSYCHOSIS 92 0.0372
64 TACHYPHRENIA 125 0.0361
65 VENTRICULAR SEPTAL DEFECT 205 0.0358
66 OBSESSIVE-COMPULSIVE DISORDER 287 0.0357
67 JAUNDICE CHOLESTATIC 126 0.0356
68 MAJOR DEPRESSION 260 0.0355
69 PARANOIA 613 0.0355
70 SCHIZOPHRENIA 431 0.0354
71 PERSECUTORY DELUSION 88 0.0353
72 SUICIDE ATTEMPT 2133 0.0351
73 GAMBLING DISORDER 95 0.0351
74 MYDRIASIS 451 0.0351
75 HALLUCINATION, AUDITORY 558 0.0351
76 TEMPERATURE REGULATION DISORDER 77 0.0345
77 TORTICOLLIS 73 0.0344
78 HOMICIDAL IDEATION 139 0.0343
79 PRIAPISM 118 0.0342
80 HEART DISEASE CONGENITAL 121 0.0342
81 SOPOR 448 0.0338
82 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 347 0.0338
83 BRADYPHRENIA 219 0.0335
84 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 138 0.0332
85 MATERNAL EXPOSURE DURING BREAST FEEDING 134 0.0330
86 MANIA 535 0.0325
87 MUSCLE RIGIDITY 386 0.0322
88 URINARY HESITATION 76 0.0318
89 IMPULSIVE BEHAVIOUR 119 0.0317
90 COMPLETED SUICIDE 2603 0.0312
91 SLEEP TERROR 131 0.0311
92 ALCOHOL ABUSE 83 0.0310
93 SUICIDAL IDEATION 2806 0.0306
94 URINARY TRACT DISORDER 136 0.0302
95 APATHY 433 0.0297
96 ALCOHOL POISONING 79 0.0295
97 BLOOD PROLACTIN INCREASED 139 0.0294
98 SOCIAL AVOIDANT BEHAVIOUR 170 0.0294
99 MATERNAL EXPOSURE TIMING UNSPECIFIED 110 0.0293
100 PSYCHOTIC DISORDER 862 0.0292
101 DELUSION 453 0.0291
102 HALLUCINATION, VISUAL 613 0.0290
103 COMA SCALE ABNORMAL 83 0.0286
104 PERSONALITY DISORDER 75 0.0286
105 POTENTIATING DRUG INTERACTION 96 0.0286
106 NEONATAL RESPIRATORY DISTRESS SYNDROME 101 0.0285
107 SELF INJURIOUS BEHAVIOUR 87 0.0285
108 ELECTROCARDIOGRAM QT PROLONGED 1025 0.0285
109 FEELING OF DESPAIR 132 0.0283
110 DRUG INTERACTION 4486 0.0282
111 ABNORMAL DREAMS 762 0.0276
112 NIGHTMARE 949 0.0274
113 CONGENITAL ANOMALY 210 0.0271
114 DRUG ABUSE 2172 0.0261
115 HYPONATRAEMIA 1461 0.0259
116 RHINITIS ALLERGIC 114 0.0256
117 SALIVARY HYPERSECRETION 254 0.0254
118 DYSTONIA 484 0.0249
119 HYPERACUSIS 92 0.0247
120 AGITATION 1814 0.0247
121 RESTLESSNESS 901 0.0246
122 BREATH SOUNDS ABNORMAL 121 0.0245
123 ABNORMAL LOSS OF WEIGHT 167 0.0245
124 POST-TRAUMATIC STRESS DISORDER 163 0.0243
125 DYSKINESIA 987 0.0243
126 RESTLESS LEGS SYNDROME 437 0.0240
127 SEDATION 624 0.0238
128 PSYCHOMOTOR HYPERACTIVITY 395 0.0238
129 WITHDRAWAL SYNDROME 998 0.0237
130 MYOPATHY 205 0.0237
131 DYSPHEMIA 104 0.0237
132 AFFECTIVE DISORDER 185 0.0235
133 MACULOPATHY 83 0.0234
134 LOGORRHOEA 82 0.0232
135 FOETAL EXPOSURE DURING PREGNANCY 1884 0.0232
136 TENSION 139 0.0228
137 NEUROLOGICAL SYMPTOM 130 0.0227
138 NYSTAGMUS 120 0.0226
139 HAEMORRHAGIC STROKE 176 0.0225
140 UPPER GASTROINTESTINAL HAEMORRHAGE 373 0.0221
141 PANIC REACTION 160 0.0221
142 HEAD DISCOMFORT 391 0.0221
143 DISSOCIATION 169 0.0220
144 HYPERTONIA 125 0.0218
145 PANIC ATTACK 795 0.0218
146 EXPOSURE VIA BREAST MILK 86 0.0216
147 HYPERPROLACTINAEMIA 140 0.0216
148 TOXICITY TO VARIOUS AGENTS 3604 0.0214
149 PANIC DISORDER 82 0.0212
150 ANAL INCONTINENCE 190 0.0211
151 END STAGE RENAL DISEASE 385 0.0211
152 ERECTILE DYSFUNCTION 537 0.0209
153 AGGRESSION 1039 0.0207
154 POLYDIPSIA 82 0.0207
155 MUSCLE TWITCHING 477 0.0207
156 FOETAL DEATH 106 0.0204
157 SNORING 77 0.0203
158 EYE MOVEMENT DISORDER 138 0.0201
159 DELIRIUM 698 0.0201
160 POISONING 252 0.0200
161 DECREASED INTEREST 118 0.0200
162 ARTERIOSCLEROSIS CORONARY ARTERY 131 0.0198
163 CARDIAC MURMUR 171 0.0197
164 DEPRESSED MOOD 1039 0.0196
165 NEUTROPHIL COUNT INCREASED 201 0.0196
166 PETIT MAL EPILEPSY 100 0.0196
167 HYPERTHERMIA 149 0.0195
168 HALLUCINATION 1467 0.0194
169 PROTEIN URINE PRESENT 97 0.0194
170 ORTHOSTATIC HYPOTENSION 338 0.0194
171 BEHAVIOUR DISORDER 105 0.0194
172 EUPHORIC MOOD 198 0.0193
173 PSYCHIATRIC SYMPTOM 141 0.0191
174 ENURESIS 77 0.0190
175 ENERGY INCREASED 112 0.0190
176 SARCOIDOSIS 90 0.0189
177 TORSADE DE POINTES 148 0.0188
178 ANHEDONIA 494 0.0188
179 GENERALISED TONIC-CLONIC SEIZURE 311 0.0188
180 FOETAL GROWTH RESTRICTION 114 0.0187
181 SINUS TACHYCARDIA 266 0.0187
182 HYPERNATRAEMIA 91 0.0182
183 OCULAR DISCOMFORT 205 0.0182
184 HYPERVENTILATION 105 0.0181
185 HAEMATEMESIS 458 0.0180
186 HYPERPHAGIA 72 0.0180
187 ALCOHOLISM 77 0.0180
188 DISORIENTATION 712 0.0179
189 BLEPHAROSPASM 113 0.0179
190 CONFUSIONAL STATE 2893 0.0179
191 ABNORMAL BEHAVIOUR 707 0.0178
192 TREMOR 2958 0.0178
193 NASAL POLYPS 87 0.0177
194 DEPRESSION 4008 0.0176
195 DYSARTHRIA 658 0.0175
196 DRUG LEVEL INCREASED 288 0.0174
197 PRE-ECLAMPSIA 82 0.0172
198 THINKING ABNORMAL 320 0.0172
199 ANXIETY 4845 0.0170
200 EXTRAPYRAMIDAL DISORDER 420 0.0169
201 DISTURBANCE IN ATTENTION 912 0.0169
202 CHRONIC KIDNEY DISEASE 1283 0.0169
203 CARDIO-RESPIRATORY ARREST 706 0.0169
204 METABOLIC DISORDER 98 0.0169
205 MIOSIS 135 0.0168
206 FORMICATION 117 0.0168
207 OBSTRUCTIVE AIRWAYS DISORDER 187 0.0168
208 URINARY INCONTINENCE 495 0.0167
209 DEPRESSED LEVEL OF CONSCIOUSNESS 659 0.0166
210 ALTERED STATE OF CONSCIOUSNESS 360 0.0166
211 PRESYNCOPE 403 0.0166
212 GALACTORRHOEA 106 0.0165
213 BRONCHIECTASIS 111 0.0165
214 MICTURITION URGENCY 188 0.0164
215 COMA 783 0.0164
216 ABNORMAL WEIGHT GAIN 203 0.0164
217 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 145 0.0164
218 BUNDLE BRANCH BLOCK RIGHT 75 0.0163
219 UNRESPONSIVE TO STIMULI 421 0.0163
220 BIPOLAR DISORDER 176 0.0162
221 SOMNAMBULISM 106 0.0161
222 RED BLOOD CELL SEDIMENTATION RATE INCREASED 178 0.0161
223 COGNITIVE DISORDER 751 0.0161
224 RHABDOMYOLYSIS 668 0.0160
225 MENTAL IMPAIRMENT 388 0.0160
226 NIGHT SWEATS 515 0.0160
227 BRAIN INJURY 160 0.0159
228 SINUS BRADYCARDIA 153 0.0158
229 OVERWEIGHT 84 0.0156
230 TINNITUS 716 0.0156
231 HYPERAESTHESIA 128 0.0156
232 MEDICATION ERROR 866 0.0156
233 PRE-EXISTING CONDITION IMPROVED 97 0.0155
234 PHOTOPHOBIA 292 0.0155
235 INCONTINENCE 164 0.0155
236 PERSONALITY CHANGE 144 0.0155
237 ASPHYXIA 126 0.0154
238 SKIN NECROSIS 80 0.0154
239 RESPIRATORY DEPRESSION 189 0.0154
240 RESPIRATORY ARREST 424 0.0154
241 OBESITY 245 0.0154
242 URINARY RETENTION 513 0.0154
243 TACHYCARDIA 1354 0.0152
244 HYPOTONIA 152 0.0152
245 BRAIN FOG 238 0.0152
246 MOOD SWINGS 480 0.0150
247 INFARCTION 103 0.0150
248 COORDINATION ABNORMAL 209 0.0150
249 SLEEP DISORDER 1055 0.0149
250 FEELING DRUNK 110 0.0148
251 HYPOKALAEMIA 683 0.0148
252 IRRITABILITY 888 0.0148
253 AFFECT LABILITY 142 0.0147
254 MUSCLE TIGHTNESS 239 0.0147
255 ANGER 497 0.0147
256 BLOOD CREATINE PHOSPHOKINASE INCREASED 422 0.0146
257 CIRCULATORY COLLAPSE 249 0.0146
258 MENTAL STATUS CHANGES 405 0.0146
259 SOMNOLENCE 2914 0.0145
260 HEAVY MENSTRUAL BLEEDING 130 0.0144
261 DYSPHORIA 73 0.0144
262 CARDIOMEGALY 177 0.0144
263 GASTROINTESTINAL MOTILITY DISORDER 77 0.0144
264 DYSLIPIDAEMIA 73 0.0144
265 SENSATION OF FOREIGN BODY 121 0.0143
266 HYPERHIDROSIS 1835 0.0142
267 FAECALOMA 78 0.0142
268 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 679 0.0141
269 LOWER GASTROINTESTINAL HAEMORRHAGE 104 0.0141
270 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 72 0.0140
271 RHEUMATOID FACTOR POSITIVE 81 0.0140
272 IMPAIRED QUALITY OF LIFE 201 0.0140
273 DRUG WITHDRAWAL SYNDROME NEONATAL 207 0.0140
274 DROOLING 96 0.0139
275 SUBSTANCE ABUSE 113 0.0139
276 MATERNAL DRUGS AFFECTING FOETUS 106 0.0138
277 VASCULITIS 161 0.0138
278 DIZZINESS POSTURAL 134 0.0138
279 NEPHROPATHY 129 0.0138
280 DIPLOPIA 355 0.0137
281 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 74 0.0136
282 HYPOKINESIA 197 0.0136
283 MELAENA 297 0.0135
284 TRICUSPID VALVE INCOMPETENCE 107 0.0135
285 ASPIRATION 147 0.0134
286 ARTERIOSCLEROSIS 126 0.0134
287 SPEECH DISORDER 700 0.0133
288 SEIZURE 1542 0.0133
289 HYPERSOMNIA 382 0.0133
290 HYPERTRIGLYCERIDAEMIA 78 0.0133
291 HEPATIC STEATOSIS 248 0.0133
292 INCOHERENT 86 0.0133
293 CRYING 480 0.0132
294 IMPAIRED GASTRIC EMPTYING 180 0.0132
295 BALANCE DISORDER 1138 0.0132
296 SENSORY DISTURBANCE 211 0.0131
297 DRUG TOXICITY 178 0.0131
298 MATERNAL EXPOSURE DURING PREGNANCY 1164 0.0130
299 DYSGRAPHIA 86 0.0130
300 MOUTH ULCERATION 275 0.0130
301 BLOOD MAGNESIUM DECREASED 112 0.0130
302 TACHYPNOEA 176 0.0129
303 PNEUMONIA ASPIRATION 323 0.0129
304 AMNESIA 837 0.0129
305 PRODUCT SUBSTITUTION ISSUE 736 0.0128
306 INSOMNIA 3399 0.0127
307 BRADYCARDIA 675 0.0127
308 ACUTE KIDNEY INJURY 1943 0.0127
309 PULMONARY FIBROSIS 243 0.0127
310 FEELING OF BODY TEMPERATURE CHANGE 74 0.0126
311 LETHARGY 726 0.0126
312 ELECTROCARDIOGRAM ABNORMAL 99 0.0126
313 SWOLLEN TONGUE 394 0.0126
314 CARDIAC ARREST 1038 0.0126
315 MENTAL DISORDER 546 0.0125
316 GASTRITIS 329 0.0125
317 FULL BLOOD COUNT ABNORMAL 132 0.0125
318 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 77 0.0125
319 EXTRASYSTOLES 87 0.0124
320 BRAIN OEDEMA 157 0.0124
321 HICCUPS 102 0.0124
322 PREMATURE BABY 374 0.0124
323 FEAR 333 0.0124
324 DRY MOUTH 1004 0.0124
325 ATAXIA 146 0.0123
326 WRONG PRODUCT ADMINISTERED 83 0.0123
327 VENTRICULAR TACHYCARDIA 201 0.0122
328 ECCHYMOSIS 83 0.0121
329 MOVEMENT DISORDER 388 0.0121
330 TREATMENT NONCOMPLIANCE 659 0.0120
331 FLANK PAIN 111 0.0118
332 DECUBITUS ULCER 96 0.0118
333 VERTIGO 718 0.0118
334 ACIDOSIS 90 0.0118
335 COLD SWEAT 207 0.0117
336 SLEEP APNOEA SYNDROME 224 0.0117
337 APHTHOUS ULCER 91 0.0117
338 FALL 3898 0.0117
339 METABOLIC ACIDOSIS 373 0.0117
340 POLYURIA 95 0.0116
341 EXPOSURE DURING PREGNANCY 721 0.0116
342 PHOTOSENSITIVITY REACTION 190 0.0115
343 SYNCOPE 1151 0.0115
344 TARDIVE DYSKINESIA 324 0.0115
345 POOR QUALITY SLEEP 247 0.0115
346 GENERALISED OEDEMA 142 0.0115
347 GASTROINTESTINAL PAIN 126 0.0114
348 LEUKOCYTOSIS 207 0.0114
349 SENSORY LOSS 92 0.0114
350 DRUG USE DISORDER 96 0.0114
351 DEFAECATION URGENCY 80 0.0114
352 VITAMIN D DEFICIENCY 111 0.0114
353 GASTROOESOPHAGEAL REFLUX DISEASE 915 0.0114
354 HEPATOTOXICITY 253 0.0114
355 CHOLELITHIASIS 372 0.0113
356 PHARYNGEAL SWELLING 110 0.0112
357 HEPATIC CYTOLYSIS 143 0.0112
358 LIVER FUNCTION TEST ABNORMAL 325 0.0112
359 HYPOTHERMIA 113 0.0112
360 CARDIAC FLUTTER 72 0.0111
361 BLOOD URINE PRESENT 211 0.0111
362 MOOD ALTERED 303 0.0111
363 SUBARACHNOID HAEMORRHAGE 113 0.0111
364 HEPATITIS ACUTE 72 0.0111
365 TROPONIN INCREASED 84 0.0110
366 WHEEZING 652 0.0110
367 LOSS OF CONSCIOUSNESS 1403 0.0109
368 MEMORY IMPAIRMENT 1502 0.0109
369 RESPIRATORY RATE INCREASED 97 0.0109
370 EOSINOPHILIA 191 0.0109
371 THERMAL BURN 77 0.0108
372 TOXIC EPIDERMAL NECROLYSIS 164 0.0108
373 BODY TEMPERATURE INCREASED 220 0.0108
374 INCREASED APPETITE 206 0.0108
375 PULMONARY CONGESTION 142 0.0108
376 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 562 0.0108
377 APPETITE DISORDER 71 0.0107
378 HEAD INJURY 336 0.0106
379 HEPATOCELLULAR INJURY 150 0.0106
380 APNOEA 82 0.0105
381 DRUG LEVEL DECREASED 107 0.0105
382 COELIAC DISEASE 103 0.0105
383 EMOTIONAL DISORDER 323 0.0105
384 PALPITATIONS 1225 0.0104
385 HYPOTHYROIDISM 334 0.0104
386 INITIAL INSOMNIA 107 0.0104
387 APHASIA 314 0.0104
388 PRESCRIBED UNDERDOSE 207 0.0104
389 HYPOPHAGIA 265 0.0104
390 STATUS EPILEPTICUS 117 0.0103
391 ECONOMIC PROBLEM 157 0.0103
392 CONDITION AGGRAVATED 3147 0.0103
393 RENAL INJURY 307 0.0103
394 MOTOR DYSFUNCTION 105 0.0103
395 HYPOXIA 362 0.0103
396 SUBDURAL HAEMATOMA 147 0.0103
397 DYSURIA 376 0.0102
398 URINE OUTPUT DECREASED 89 0.0102
399 FAECES SOFT 74 0.0102
400 ACUTE RESPIRATORY FAILURE 195 0.0101
401 SUDDEN DEATH 107 0.0101
402 PALLOR 275 0.0101
403 PANCREATITIS ACUTE 227 0.0101
404 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 171 0.0101
405 AMENORRHOEA 176 0.0100
406 MITRAL VALVE INCOMPETENCE 113 0.0100
407 FEELING JITTERY 189 0.0099
408 COVID-19 PNEUMONIA 117 0.0099
409 MIDDLE INSOMNIA 185 0.0099
410 CEREBRAL DISORDER 73 0.0099
411 HYPOMAGNESAEMIA 137 0.0098
412 NECK PAIN 548 0.0098
413 FAECES DISCOLOURED 212 0.0098
414 RIB FRACTURE 201 0.0098
415 VITREOUS FLOATERS 96 0.0098
416 EAR DISCOMFORT 100 0.0097
417 CHOLESTASIS 187 0.0097
418 HOSPICE CARE 96 0.0097
419 CLOSTRIDIUM DIFFICILE COLITIS 103 0.0097
420 IMPAIRED WORK ABILITY 207 0.0097
421 DIZZINESS 4829 0.0097
422 INTERNATIONAL NORMALISED RATIO INCREASED 276 0.0097
423 INCREASED TENDENCY TO BRUISE 89 0.0097
424 ABNORMAL FAECES 79 0.0096
425 DECREASED ACTIVITY 104 0.0096
426 CARPAL TUNNEL SYNDROME 135 0.0096
427 INTERVERTEBRAL DISC DEGENERATION 89 0.0096
428 DRUG SCREEN POSITIVE 76 0.0096
429 WHITE BLOOD CELL COUNT INCREASED 368 0.0096
430 DECREASED APPETITE 2220 0.0095
431 BLOOD ALKALINE PHOSPHATASE INCREASED 237 0.0095
432 SPINAL PAIN 111 0.0095
433 THIRST 169 0.0094
434 EATING DISORDER 201 0.0094
435 PARAESTHESIA 1482 0.0094
436 EAR PAIN 183 0.0094
437 VOMITING 4424 0.0094
438 SWELLING FACE 612 0.0094
439 DYSSTASIA 274 0.0094
440 RENAL TUBULAR NECROSIS 92 0.0094
441 BREAST PAIN 100 0.0094
442 FEELING COLD 261 0.0094
443 VITAMIN D DECREASED 80 0.0093
444 RENAL FAILURE 1239 0.0093
445 SUPRAVENTRICULAR TACHYCARDIA 89 0.0093
446 MUSCULAR WEAKNESS 1054 0.0093
447 FACIAL PARALYSIS 79 0.0093
448 HYPERCALCAEMIA 114 0.0092
449 DEMENTIA 258 0.0092
450 PETECHIAE 96 0.0092
451 FEELING ABNORMAL 2201 0.0092
452 POLLAKIURIA 382 0.0092
453 CYANOSIS 144 0.0091
454 PYELONEPHRITIS 79 0.0091
455 WEIGHT INCREASED 2041 0.0091
456 SKIN LACERATION 99 0.0091
457 HAEMATURIA 311 0.0091
458 ABDOMINAL PAIN 2105 0.0090
459 MIGRAINE 863 0.0090
460 PULMONARY OEDEMA 404 0.0090
461 KIDNEY INFECTION 177 0.0090
462 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 86 0.0090
463 MULTIPLE ORGAN DYSFUNCTION SYNDROME 255 0.0090
464 DERMATITIS ALLERGIC 113 0.0090
465 HAIR DISORDER 74 0.0090
466 MUSCULOSKELETAL CHEST PAIN 139 0.0090
467 PLATELET COUNT INCREASED 117 0.0090
468 INTENTIONAL PRODUCT MISUSE 785 0.0090
469 EPILEPSY 274 0.0090
470 RETCHING 191 0.0089
471 MALNUTRITION 100 0.0089
472 FRUSTRATION TOLERANCE DECREASED 72 0.0089
473 BASAL CELL CARCINOMA 139 0.0089
474 ENCEPHALOPATHY 218 0.0089
475 PULMONARY HYPERTENSION 184 0.0088
476 OSTEOPENIA 134 0.0088
477 HAEMATOCRIT DECREASED 175 0.0088
478 NOCTURIA 107 0.0088
479 MUSCULOSKELETAL STIFFNESS 772 0.0088
480 DISEASE RECURRENCE 419 0.0088
481 ERYTHEMA MULTIFORME 82 0.0088
482 LIP SWELLING 291 0.0087
483 URINARY TRACT INFECTION 1490 0.0087
484 VENTRICULAR FIBRILLATION 97 0.0087
485 IMPAIRED DRIVING ABILITY 99 0.0087
486 NAUSEA 6887 0.0087
487 DYSPEPSIA 856 0.0087
488 PRODUCTIVE COUGH 415 0.0087
489 PRODUCT PRESCRIBING ERROR 207 0.0087
490 NERVOUSNESS 454 0.0087
491 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 618 0.0087
492 BLOOD IRON DECREASED 103 0.0087
493 HEPATIC ENCEPHALOPATHY 81 0.0087
494 HYPOTENSION 1731 0.0086
495 JOINT STIFFNESS 225 0.0086
496 QUALITY OF LIFE DECREASED 115 0.0086
497 DIARRHOEA 5527 0.0086
498 C-REACTIVE PROTEIN INCREASED 311 0.0085
499 MOBILITY DECREASED 614 0.0085
500 SLUGGISHNESS 87 0.0085
501 MUSCLE ATROPHY 108 0.0085
502 GAIT DISTURBANCE 1630 0.0085
503 NEURALGIA 207 0.0085
504 DYSPHAGIA 805 0.0085
505 MUSCLE SPASTICITY 104 0.0085
506 MYALGIA 1439 0.0085
507 DEHYDRATION 1128 0.0084
508 UROSEPSIS 78 0.0084
509 OVERDOSE 1817 0.0084
510 EYE PAIN 475 0.0084
511 BLOOD PRESSURE SYSTOLIC INCREASED 164 0.0084
512 HEART RATE INCREASED 833 0.0084
513 HUNGER 117 0.0084
514 PRESCRIBED OVERDOSE 162 0.0084
515 DRUG INTOLERANCE 808 0.0084
516 NODULE 109 0.0083
517 DRUG-INDUCED LIVER INJURY 262 0.0083
518 WRIST FRACTURE 100 0.0083
519 PSYCHOLOGICAL TRAUMA 72 0.0083
520 NEUROTOXICITY 146 0.0083
521 BLOOD BILIRUBIN INCREASED 225 0.0083
522 TUBULOINTERSTITIAL NEPHRITIS 156 0.0083
523 LYMPHOCYTE COUNT DECREASED 147 0.0083
524 CHOLECYSTITIS 99 0.0083
525 BLOOD PRESSURE FLUCTUATION 199 0.0083
526 SMALL INTESTINAL OBSTRUCTION 102 0.0083
527 BLOOD POTASSIUM DECREASED 249 0.0083
528 HIATUS HERNIA 107 0.0083
529 HEADACHE 5179 0.0083
530 CONTUSION 795 0.0082
531 HYPOGLYCAEMIA 400 0.0082
532 ASTHENIA 3099 0.0082
533 ULCER 131 0.0082
534 FEEDING DISORDER 167 0.0082
535 EMPHYSEMA 83 0.0082
536 PAIN IN JAW 233 0.0082
537 VENTRICULAR EXTRASYSTOLES 85 0.0082
538 CHILLS 958 0.0082
539 JOINT DISLOCATION 86 0.0081
540 HEPATITIS 208 0.0081
541 SPUTUM DISCOLOURED 77 0.0081
542 CLOSTRIDIUM DIFFICILE INFECTION 177 0.0081
543 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 139 0.0081
544 GLAUCOMA 156 0.0081
545 RESPIRATORY DISTRESS 223 0.0081
546 SECRETION DISCHARGE 101 0.0081
547 OESOPHAGITIS 88 0.0080
548 BODY HEIGHT DECREASED 86 0.0080
549 VISION BLURRED 1104 0.0080
550 ORAL PAIN 180 0.0080
551 THERAPY CHANGE 79 0.0080
552 SPLENOMEGALY 94 0.0080
553 ABDOMINAL PAIN UPPER 1652 0.0080
554 ARRHYTHMIA 379 0.0080
555 FATIGUE 6230 0.0080
556 ASCITES 235 0.0080
557 LIGAMENT SPRAIN 79 0.0080
558 LACTIC ACIDOSIS 258 0.0080
559 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 437 0.0080
560 CHEST DISCOMFORT 815 0.0080
561 OXYGEN SATURATION DECREASED 447 0.0079
562 OSTEOARTHRITIS 337 0.0079
563 LIVER INJURY 195 0.0079
564 DIABETIC KETOACIDOSIS 190 0.0079
565 HAEMATOMA 204 0.0079
566 LOWER RESPIRATORY TRACT INFECTION 358 0.0079
567 TOOTHACHE 142 0.0078
568 PULMONARY EMBOLISM 745 0.0078
569 CONTRAINDICATED PRODUCT ADMINISTERED 237 0.0078
570 IRON DEFICIENCY ANAEMIA 72 0.0078
571 HAIR COLOUR CHANGES 97 0.0078
572 INSURANCE ISSUE 119 0.0078
573 FLATULENCE 441 0.0078
574 HAEMORRHAGE INTRACRANIAL 116 0.0078
575 ACCIDENTAL OVERDOSE 283 0.0077
576 HAIR TEXTURE ABNORMAL 103 0.0077
577 PARAESTHESIA ORAL 111 0.0077
578 HYPERKALAEMIA 269 0.0077
579 THERAPY CESSATION 390 0.0076
580 HAEMATOCHEZIA 419 0.0076
581 CHOKING 148 0.0076
582 MUSCLE SPASMS 1391 0.0076
583 SKIN INFECTION 85 0.0076
584 CHEST PAIN 1402 0.0076
585 CAESAREAN SECTION 88 0.0076
586 ANKLE FRACTURE 117 0.0076
587 CONSTIPATION 1646 0.0075
588 THROAT TIGHTNESS 204 0.0075
589 CHROMATURIA 170 0.0075
590 RECTAL HAEMORRHAGE 323 0.0075
591 CYSTITIS 239 0.0075
592 HYPOAESTHESIA ORAL 113 0.0075
593 FOOT DEFORMITY 83 0.0075
594 ELECTROLYTE IMBALANCE 87 0.0075
595 GASTRIC ULCER 142 0.0075
596 BLINDNESS 304 0.0075
597 WEIGHT DECREASED 2082 0.0075
598 RENAL PAIN 79 0.0074
599 MALAISE 3265 0.0074
600 FREQUENT BOWEL MOVEMENTS 201 0.0074
601 TOOTH FRACTURE 82 0.0074
602 ANGIOEDEMA 328 0.0074
603 HEART RATE DECREASED 259 0.0074
604 HYPERTENSION 1561 0.0074
605 GAIT INABILITY 246 0.0074
606 BLOOD TRIGLYCERIDES INCREASED 130 0.0074
607 LYMPHOPENIA 104 0.0073
608 HOT FLUSH 554 0.0073
609 PHARYNGEAL OEDEMA 113 0.0073
610 SEPSIS 819 0.0073
611 HAEMOGLOBIN DECREASED 754 0.0073
612 HEPATOMEGALY 72 0.0073
613 DENTAL CARIES 81 0.0073
614 FIBROMYALGIA 178 0.0073
615 OVARIAN CYST 73 0.0073
616 MASS 102 0.0073
617 HYPERTENSIVE CRISIS 81 0.0073
618 TRANSAMINASES INCREASED 161 0.0072
619 DYSPHONIA 423 0.0072
620 PERICARDIAL EFFUSION 167 0.0072
621 HEART RATE IRREGULAR 163 0.0072
622 SCRATCH 76 0.0072
623 HYPERLIPIDAEMIA 86 0.0072
624 TASTE DISORDER 146 0.0072
625 SKIN ULCER 186 0.0072
626 PNEUMONIA 2326 0.0072
627 SHOCK 165 0.0072
628 RESPIRATORY FAILURE 523 0.0072
629 TEMPERATURE INTOLERANCE 74 0.0072
630 BACK PAIN 1662 0.0071
631 BEDRIDDEN 94 0.0071
632 HYPOAESTHESIA 1068 0.0071
633 DRUG WITHDRAWAL SYNDROME 625 0.0071
634 VISUAL IMPAIRMENT 880 0.0071
635 RED BLOOD CELL COUNT DECREASED 203 0.0071
636 DYSPNOEA EXERTIONAL 267 0.0071
637 HEMIPARESIS 120 0.0071
638 BURNING SENSATION 496 0.0071
639 MYOCARDITIS 81 0.0071
640 MADAROSIS 82 0.0071
641 ORAL DISCOMFORT 98 0.0070
642 GASTROINTESTINAL HAEMORRHAGE 587 0.0070
643 HAEMORRHOIDS 137 0.0070
644 ASPARTATE AMINOTRANSFERASE INCREASED 373 0.0070
645 FEELING HOT 429 0.0070
646 ABDOMINAL DISCOMFORT 1167 0.0070
647 RESPIRATORY DISORDER 208 0.0069
648 HIP FRACTURE 223 0.0069
649 BLOOD COUNT ABNORMAL 105 0.0069
650 NERVE INJURY 77 0.0069
651 BLOOD PRESSURE INCREASED 1055 0.0069
652 THROAT IRRITATION 309 0.0069
653 EPISTAXIS 515 0.0069
654 GAMMA-GLUTAMYLTRANSFERASE INCREASED 152 0.0069
655 ACUTE RESPIRATORY DISTRESS SYNDROME 121 0.0068
656 DYSPNOEA 3856 0.0068
657 HAEMOPTYSIS 190 0.0068
658 PREMATURE DELIVERY 108 0.0068
659 AGRANULOCYTOSIS 126 0.0068
660 ROTATOR CUFF SYNDROME 87 0.0068
661 PERIPHERAL COLDNESS 93 0.0068
662 DISCOMFORT 413 0.0068
663 BLOOD CHOLESTEROL INCREASED 315 0.0068
664 PERIPHERAL SWELLING 1040 0.0067
665 THERAPY NON-RESPONDER 303 0.0067
666 JAUNDICE 181 0.0067
667 INTERVERTEBRAL DISC PROTRUSION 147 0.0067
668 ABDOMINAL DISTENSION 700 0.0067
669 BLOOD CREATININE INCREASED 437 0.0067
670 BLOOD SODIUM DECREASED 126 0.0067
671 INTENTIONAL PRODUCT USE ISSUE 585 0.0067
672 STAPHYLOCOCCAL INFECTION 220 0.0067
673 IRRITABLE BOWEL SYNDROME 143 0.0067
674 GASTROINTESTINAL DISORDER 597 0.0067
675 PRODUCT DOSE OMISSION 434 0.0066
676 CEREBRAL HAEMORRHAGE 238 0.0066
677 GASTROENTERITIS VIRAL 120 0.0066
678 DYSMENORRHOEA 88 0.0066
679 OROPHARYNGEAL PAIN 614 0.0066
680 CANDIDA INFECTION 112 0.0066
681 NASAL CONGESTION 389 0.0066
682 PNEUMONITIS 180 0.0066
683 THERAPY PARTIAL RESPONDER 103 0.0066
684 ASTHMA 745 0.0066
685 IMMUNODEFICIENCY 98 0.0066
686 ALANINE AMINOTRANSFERASE INCREASED 403 0.0066
687 GENERAL PHYSICAL HEALTH DETERIORATION 757 0.0065
688 FOOT FRACTURE 124 0.0065
689 DIABETES MELLITUS 498 0.0065
690 WOUND 182 0.0065
691 HEPATIC ENZYME INCREASED 443 0.0065
692 INTENTIONAL DOSE OMISSION 185 0.0065
693 LIVER FUNCTION TEST INCREASED 139 0.0065
694 ATRIAL FIBRILLATION 630 0.0065
695 BLISTER 363 0.0065
696 AGEUSIA 161 0.0064
697 HYPERGLYCAEMIA 235 0.0064
698 BLOOD PRESSURE DECREASED 427 0.0064
699 CARDIOGENIC SHOCK 92 0.0064
700 TYPE 2 DIABETES MELLITUS 215 0.0064
701 PRODUCT USE IN UNAPPROVED INDICATION 1579 0.0064
702 OSTEOPOROSIS 262 0.0064
703 COUGH 1785 0.0064
704 COLITIS 241 0.0064
705 OEDEMA PERIPHERAL 771 0.0063
706 ARTHRALGIA 2630 0.0063
707 PHARMACEUTICAL PRODUCT COMPLAINT 164 0.0063
708 NERVOUS SYSTEM DISORDER 197 0.0063
709 ERUCTATION 122 0.0063
710 DEVICE RELATED INFECTION 97 0.0063
711 BLOOD PRESSURE ABNORMAL 125 0.0063
712 PULMONARY MASS 93 0.0062
713 SPINAL FRACTURE 125 0.0062
714 RASH PRURITIC 338 0.0062
715 SKIN LESION 171 0.0062
716 DRY EYE 311 0.0062
717 ISCHAEMIC STROKE 111 0.0062
718 MUSCULOSKELETAL DISCOMFORT 107 0.0062
719 NEPHROLITHIASIS 285 0.0062
720 LIMB DISCOMFORT 191 0.0062
721 BLOOD POTASSIUM INCREASED 100 0.0062
722 SKIN DISCOLOURATION 283 0.0062
723 IMMUNE SYSTEM DISORDER 81 0.0061
724 JOINT INJURY 131 0.0061
725 PAIN IN EXTREMITY 1802 0.0061
726 MULTIPLE SCLEROSIS RELAPSE 417 0.0061
727 VIRAL INFECTION 202 0.0061
728 UPPER RESPIRATORY TRACT INFECTION 280 0.0061
729 FLUID OVERLOAD 88 0.0060
730 ILEUS 75 0.0060
731 UPPER LIMB FRACTURE 120 0.0060
732 HEPATIC CIRRHOSIS 113 0.0060
733 ACTIVITIES OF DAILY LIVING IMPAIRED 119 0.0060
734 INFLUENZA 670 0.0060
735 PELVIC PAIN 109 0.0060
736 LEUKOPENIA 300 0.0060
737 ARTHRITIS 471 0.0060
738 LOWER LIMB FRACTURE 115 0.0060
739 SWELLING 559 0.0060
740 ABDOMINAL PAIN LOWER 151 0.0060
741 HYPOCALCAEMIA 113 0.0060
742 PHARYNGITIS 74 0.0060
743 TRANSIENT ISCHAEMIC ATTACK 201 0.0060
744 LOCALISED INFECTION 144 0.0059
745 CARDIOMYOPATHY 88 0.0059
746 ACUTE MYOCARDIAL INFARCTION 175 0.0059
747 DEAFNESS 155 0.0059
748 DRUG ERUPTION 105 0.0059
749 PRODUCT DISPENSING ERROR 129 0.0059
750 VAGINAL HAEMORRHAGE 257 0.0059
751 PRODUCT DOSE OMISSION IN ERROR 167 0.0059
752 CATARACT 351 0.0059
753 CELLULITIS 297 0.0059
754 STEVENS-JOHNSON SYNDROME 131 0.0059
755 GALLBLADDER DISORDER 105 0.0059
756 INFLAMMATION 302 0.0058
757 DIVERTICULITIS 162 0.0058
758 OEDEMA 316 0.0058
759 BRONCHITIS 431 0.0058
760 COVID-19 1021 0.0058
761 PYREXIA 2009 0.0058
762 SEASONAL ALLERGY 82 0.0058
763 PRODUCT ADMINISTRATION ERROR 117 0.0058
764 ANAEMIA 1102 0.0058
765 ORAL CANDIDIASIS 76 0.0058
766 ILLNESS 594 0.0058
767 FRACTURE 109 0.0058
768 ARTHROPATHY 320 0.0058
769 INTESTINAL OBSTRUCTION 217 0.0058
770 TOOTH DISORDER 128 0.0058
771 DYSGEUSIA 427 0.0057
772 PNEUMOTHORAX 91 0.0057
773 GINGIVAL BLEEDING 78 0.0057
774 COAGULOPATHY 95 0.0057
775 HERNIA 110 0.0057
776 GASTROENTERITIS 83 0.0057
777 HEPATIC FAILURE 171 0.0057
778 BLOOD UREA INCREASED 94 0.0056
779 TOOTH INFECTION 74 0.0056
780 OFF LABEL USE 4915 0.0056
781 SCAR 96 0.0056
782 ALOPECIA 1098 0.0056
783 APHONIA 78 0.0056
784 EYE DISORDER 183 0.0056
785 EAR INFECTION 148 0.0056
786 INFECTION 802 0.0055
787 PRURITUS 2125 0.0055
788 SNEEZING 124 0.0055
789 PAIN 3396 0.0055
790 ANOSMIA 80 0.0055
791 DRUG PRESCRIBING ERROR 106 0.0055
792 MUSCULOSKELETAL PAIN 289 0.0055
793 RENAL DISORDER 256 0.0055
794 DEEP VEIN THROMBOSIS 357 0.0055
795 RHINORRHOEA 355 0.0055
796 ACUTE HEPATIC FAILURE 75 0.0055
797 DERMATITIS 115 0.0055
798 RENAL IMPAIRMENT 461 0.0055
799 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 141 0.0055
800 FLUSHING 556 0.0055
801 TREATMENT FAILURE 453 0.0055
802 ADVERSE DRUG REACTION 491 0.0055
803 ANAPHYLACTIC REACTION 302 0.0055
804 SARS-COV-2 TEST POSITIVE 72 0.0054
805 DRUG INEFFECTIVE 7185 0.0054
806 JOINT SWELLING 657 0.0054
807 RASH MACULAR 188 0.0054
808 RESPIRATORY TRACT INFECTION 140 0.0054
809 LIMB INJURY 146 0.0054
810 PRODUCT PRESCRIBING ISSUE 117 0.0054
811 INFUSION RELATED REACTION 355 0.0054
812 SINUS DISORDER 106 0.0053
813 DRUG EFFECT INCOMPLETE 194 0.0053
814 PLEURAL EFFUSION 325 0.0053
815 THERAPEUTIC RESPONSE UNEXPECTED 239 0.0053
816 EYE SWELLING 198 0.0053
817 THROMBOSIS 428 0.0053
818 PANCREATITIS 281 0.0053
819 BRONCHOSPASM 75 0.0053
820 EMOTIONAL DISTRESS 636 0.0052
821 CENTRAL NERVOUS SYSTEM LESION 72 0.0052
822 METASTASES TO LIVER 92 0.0052
823 LUNG DISORDER 256 0.0052
824 VISUAL ACUITY REDUCED 173 0.0052
825 ABSCESS 83 0.0052
826 MUSCULOSKELETAL DISORDER 99 0.0052
827 CONVULSION 297 0.0052
828 INFLUENZA LIKE ILLNESS 427 0.0052
829 WHITE BLOOD CELL COUNT DECREASED 562 0.0052
830 PRODUCT AVAILABILITY ISSUE 118 0.0052
831 HYPERSENSITIVITY 958 0.0052
832 BONE DISORDER 94 0.0052
833 SINUSITIS 527 0.0051
834 PRODUCT USE COMPLAINT 81 0.0051
835 IMPAIRED HEALING 168 0.0051
836 HYPERTHYROIDISM 74 0.0051
837 GLOSSODYNIA 114 0.0051
838 RASH MACULO-PAPULAR 113 0.0051
839 DRUG EXPOSURE DURING PREGNANCY 172 0.0051
840 FLUID RETENTION 257 0.0050
841 TENDONITIS 78 0.0050
842 BLINDNESS UNILATERAL 71 0.0050
843 ORAL HERPES 98 0.0050
844 ABORTION SPONTANEOUS 201 0.0050
845 LYMPHADENOPATHY 177 0.0050
846 SKIN HAEMORRHAGE 74 0.0050
847 PULMONARY ARTERIAL HYPERTENSION 72 0.0050
848 ROAD TRAFFIC ACCIDENT 207 0.0049
849 LABORATORY TEST ABNORMAL 146 0.0049
850 POST PROCEDURAL COMPLICATION 95 0.0049
851 THROMBOCYTOPENIA 553 0.0049
852 SYNOVITIS 89 0.0049
853 DISABILITY 97 0.0049
854 PANCYTOPENIA 274 0.0049
855 THERAPEUTIC RESPONSE SHORTENED 162 0.0049
856 GASTRIC DISORDER 167 0.0049
857 FULL BLOOD COUNT DECREASED 98 0.0049
858 PSORIATIC ARTHROPATHY 197 0.0048
859 RASH 2098 0.0048
860 RASH ERYTHEMATOUS 230 0.0048
861 PRURITUS GENERALISED 104 0.0048
862 NEUTROPHIL COUNT DECREASED 196 0.0048
863 THERAPEUTIC PRODUCT EFFECT DECREASED 215 0.0048
864 URTICARIA 801 0.0048
865 DERMATITIS ATOPIC 252 0.0048
866 MENSTRUATION IRREGULAR 128 0.0048
867 BACTERIAL INFECTION 89 0.0048
868 MULTIPLE SCLEROSIS 228 0.0048
869 COLITIS ULCERATIVE 213 0.0048
870 INTERSTITIAL LUNG DISEASE 230 0.0047
871 STOMATITIS 288 0.0047
872 PLATELET COUNT DECREASED 506 0.0047
873 UNEVALUABLE EVENT 359 0.0047
874 NEUROPATHY PERIPHERAL 451 0.0047
875 SEPTIC SHOCK 206 0.0047
876 PSORIASIS 615 0.0047
877 ABASIA 116 0.0047
878 MENORRHAGIA 92 0.0047
879 SCIATICA 74 0.0046
880 BONE PAIN 271 0.0046
881 FACE OEDEMA 78 0.0046
882 BLOOD LACTATE DEHYDROGENASE INCREASED 73 0.0046
883 THERAPY INTERRUPTED 329 0.0046
884 RASH PAPULAR 103 0.0046
885 PROCEDURAL PAIN 127 0.0046
886 PRODUCT DOSE OMISSION ISSUE 1346 0.0046
887 NASOPHARYNGITIS 842 0.0046
888 PRODUCT USE ISSUE 857 0.0046
889 DRUG RESISTANCE 117 0.0046
890 SKIN FISSURES 89 0.0045
891 FEMUR FRACTURE 141 0.0045
892 BACK DISORDER 74 0.0045
893 PROTEINURIA 86 0.0045
894 ERYTHEMA 929 0.0045
895 ANGINA PECTORIS 129 0.0045
896 OSTEOMYELITIS 81 0.0045
897 THERAPEUTIC RESPONSE DECREASED 271 0.0045
898 HERPES ZOSTER 255 0.0044
899 HYPOACUSIS 191 0.0044
900 CARDIAC FAILURE 356 0.0044
901 SYSTEMIC LUPUS ERYTHEMATOSUS 157 0.0044
902 COMPLICATION OF DEVICE INSERTION 88 0.0044
903 NEUTROPENIA 598 0.0044
904 FEBRILE NEUTROPENIA 290 0.0044
905 LACRIMATION INCREASED 132 0.0044
906 GOUT 78 0.0043
907 OCULAR HYPERAEMIA 204 0.0043
908 TOOTH LOSS 89 0.0043
909 DIABETES MELLITUS INADEQUATE CONTROL 76 0.0043
910 INJURY 297 0.0042
911 CARDIAC DISORDER 394 0.0042
912 INTENTIONAL DRUG MISUSE 88 0.0042
913 HAEMORRHAGE 440 0.0042
914 HOSPITALISATION 646 0.0042
915 LIVER DISORDER 185 0.0042
916 CARDIAC FAILURE CONGESTIVE 335 0.0042
917 SURGERY 242 0.0041
918 DRUG ADMINISTRATION ERROR 126 0.0041
919 SKIN EXFOLIATION 341 0.0040
920 RHEUMATOID ARTHRITIS 455 0.0040
921 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 721 0.0040
922 SKIN DISORDER 132 0.0040
923 PREGNANCY 79 0.0039
924 CEREBROVASCULAR ACCIDENT 662 0.0039
925 KNEE ARTHROPLASTY 81 0.0038
926 EYE PRURITUS 129 0.0038
927 PRODUCT PHYSICAL ISSUE 77 0.0038
928 DRUG EFFECT DECREASED 205 0.0038
929 EYE IRRITATION 219 0.0038
930 LUNG NEOPLASM MALIGNANT 156 0.0038
931 RASH GENERALISED 96 0.0037
932 FUNGAL INFECTION 123 0.0037
933 RENAL FAILURE ACUTE 156 0.0037
934 DEVICE DISLOCATION 159 0.0037
935 CORONARY ARTERY DISEASE 108 0.0036
936 DRUG DOSE OMISSION 586 0.0035
937 MYOCARDIAL INFARCTION 618 0.0035
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 89 0.0035
939 BLOOD GLUCOSE DECREASED 169 0.0035
940 MUCOSAL INFLAMMATION 92 0.0035
941 NEOPLASM PROGRESSION 122 0.0035
942 PAIN OF SKIN 94 0.0035
943 UNDERDOSE 252 0.0034
944 PLASMA CELL MYELOMA 133 0.0034
945 SKIN BURNING SENSATION 244 0.0034
946 DEVICE ISSUE 302 0.0034
947 ADVERSE EVENT 308 0.0033
948 DRY SKIN 442 0.0033
949 ILL-DEFINED DISORDER 200 0.0033
950 DISEASE PROGRESSION 389 0.0033
951 DEATH 2804 0.0033
952 CEREBRAL INFARCTION 77 0.0031
953 ECZEMA 164 0.0031
954 BONE DENSITY DECREASED 98 0.0031
955 DRUG DEPENDENCE 497 0.0031
956 ANAPHYLACTIC SHOCK 79 0.0031
957 INCORRECT DOSE ADMINISTERED 693 0.0030
958 BLOOD GLUCOSE INCREASED 561 0.0030
959 INJECTION SITE MASS 110 0.0030
960 PRODUCT QUALITY ISSUE 403 0.0030
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 211 0.0030
962 NEEDLE ISSUE 85 0.0029
963 CARDIOVASCULAR DISORDER 73 0.0029
964 OSTEONECROSIS 94 0.0029
965 INJECTION SITE REACTION 196 0.0028
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 570 0.0028
967 INJECTION SITE PRURITUS 188 0.0028
968 SKIN IRRITATION 128 0.0028
969 INJECTION SITE RASH 85 0.0028
970 HEPATIC FUNCTION ABNORMAL 102 0.0027
971 EXPIRED PRODUCT ADMINISTERED 88 0.0026
972 ACNE 197 0.0026
973 GYNAECOMASTIA 80 0.0026
974 WRONG TECHNIQUE IN DRUG USAGE PROCESS 92 0.0025
975 EXTRA DOSE ADMINISTERED 102 0.0025
976 INJECTION SITE BRUISING 195 0.0024
977 DEVICE BREAKAGE 97 0.0024
978 INJECTION SITE SWELLING 179 0.0023
979 MALIGNANT NEOPLASM PROGRESSION 234 0.0023
980 INJECTION SITE PAIN 672 0.0022
981 DEVICE EXPULSION 129 0.0020
982 INJECTION SITE ERYTHEMA 246 0.0020
983 DEVICE LEAKAGE 82 0.0019
984 NEOPLASM MALIGNANT 125 0.0019
985 INJECTION SITE HAEMORRHAGE 147 0.0018
986 DEVICE MALFUNCTION 124 0.0018
987 NO ADVERSE EVENT 319 0.0018
988 BREAST CANCER 158 0.0017
989 ACCIDENTAL EXPOSURE TO PRODUCT 144 0.0014
990 DRUG DOSE OMISSION BY DEVICE 100 0.0013
991 PRODUCT STORAGE ERROR 96 0.0011